Caucasians in the Empire State that find themselves stricken with COVID can still be eligible for antibody treatment, including Pfizer’s new drug as well as monoclonal treatments, which are administered in outpatient clinics through an IV/needle, but only if they first demonstrate that they have ‘a medical condition that increase[s] their risk for severe illness,’ the document states.